Photo of Jennifer Dunlap, M.D.

Jennifer Dunlap M.D.

  •      (503) 494-2120
    • Associate Professor of Pathology School of Medicine
    • Residency Program Director
    • Medical Director, Clinical Hematology

Areas of interest

  • Hematopathology, Molecular pathology, and Surgical pathology
  • Application of novel methods in molecular pathology towards diagnosis, early detection and minimal residual disease in hematopoietic neoplasms


  • B.S., University of Texas, Austin Texas 1999
  • M.D., University of Texas Southwestern Medical School, Dallas Texas 2003
  • Residency:

    • Anatomic and Clinical Pathology, Oregon Health & Science University, 2005-2009
  • Fellowship:

    • Surgical Pathology, Oregon Health & Science University, 2009-2010
    • Hematopathology, Oregon Health & Science University, 2010-2011
  • Certifications:

    • Anatomic and Clinical Pathology (ABPath), 2009
    • Hematology (ABPath), 2011


  • "Renal ischemia" Anesthesia and Analgesia July 2008
  • "Aberrations of MYC are a common event in B-cell prolymphocytic leukemia" American Journal of Clinical Pathology September 1 2014
  • "Crosstalk between KIT and FGFR3 promotes gastrointestinal stromal tumor cell growth and drug resistance" Journal of Cancer Research March 1 2015
  • "Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms" American Journal of Clinical Pathology May 2011
  • "Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations" Blood March 6 2014
  • "High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast" Modern Pathology January 2010
  • "Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome" Leukemia Research Reports January 1 2015
  • "Determination of biological toxins using capillary electrokinetic chromatography with multiphoton-excited fluorescence" Analytical Chemistry March 15 2000
  • "Functional integration of acute myeloid leukemia into the vascular niche" Leukemia October 1 2014
  • "Rejection Versus Posttransplantation Lymphoproliferative Disorder in a Renal Transplant Recipient" American Journal of Kidney Diseases December 2008
  • "Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation" Resuscitation January 2008
  • "Cytogenetic analysis of a primary bone angiosarcoma" Cancer Genetics and Cytogenetics October 1 2009
  • "Multiplex high-throughput gene mutation analysis in acute myeloid leukemia" Human Pathology December 2012
  • "Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients" Advances in Hematology  2010
  • "Estrogen is renoprotective via a nonreceptor-dependent mechanism after cardiac arrest in vivo" Anesthesiology February 2010
  • "Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma" Breast Cancer Research and Treatment April 2010
  • "Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia" Leukemia September 2012
  • "Mutant calreticulin-expressing cells induce monocyte hyperreactivity through a paracrine mechanism" American Journal of Hematology February 1 2016
  • "Targeted next-generation sequencing in myelodysplastic syndrome and chronic myelomonocytic leukemia aids diagnosis in challenging cases and identifies frequent spliceosome mutations in transformed acute myeloid leukemia" American Journal of Clinical Pathology April 1 2016
  • "Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women" Experimental Hematology September 1 2016
  • "FGF2 from marrow microenvironment promotes resistance to FLT3 inhibitors in acute myeloid leukemia" Journal of Cancer Research November 15 2016
  • "Diffuse large B-cell lymphoma in adults aged 75 years and older" Therapeutic Advances in Hematology  2013
  • "Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent" Journal of Hematology and Oncology  2016
  • "TdT-positive Infiltrate in Inflamed Pediatric Kidney" American Journal of Surgical Pathology February 28 2017
  • "Transmission of donor-derived breast carcinoma as a recurrent mass in a keratolimbal allograft" Cornea  2017
  • "B-cell malignancies"  January 1 2016
  • "MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes" Leukemia and Lymphoma September 5 2017
  • "DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML" Leukemia and Lymphoma November 23 2017
  • "Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma" Leukemia and Lymphoma December 4 2017
  • "Acute promyelocytic leukemia presenting with features of metastatic osseous disease" Leukemia Research Reports January 1 2018

Additional information

Edit profile